The Canadian Stroke Congress welcomes the submission of late-breaking scientific abstracts or on-going clinical trials starting June 1 through to June 29, 2017. Late-breaking scientific abstracts and ongoing clinical trials may be submitted using the on-line abstract submission site (coming soon). Please follow the “Abstract Submission Guidelines” below.
Who May Submit?
Late-Breaking Scientific Abstracts
Late-breaking scientific abstracts feature recent high-impact scientific discoveries. The Canadian Stroke Congress will not accept late-breaking scientific abstracts that have been accepted for an international meeting or those that will be published (print or online) and/or presented prior to September 9, 2017.
Late-breaking scientific abstracts will be peer reviewed but will not be published in the International Journal of Stroke on-line. Highly ranked late-breaking abstracts may be featured either as oral or traditional paper display posters.
Ongoing Clinical Trials
Clinical trial information boards provide an excellent opportunity for organizers and supporters to:
- Inform Congress delegates about planned or ongoing registered clinical trials in Canada
- Educate the Canadian stroke community about the status and objectives of registered clinical trials in Canada
- Identify and recruit potential new centres
Registered trials should be in the advanced planning, recruitment or follow-up phase. Trials that have been completed and published will not be accepted.
If you did not submit an on-going clinical trial abstract during the call for abstracts, but would still like to, you may submit an abstract between June 1 and June 29, 2017. On-going clinical trials will not be peer reviewed or published in the International Journal of Stroke and will only be accepted as a display poster. Ongoing clinical trials should be randomized clinical trials or prospective observational cohort studies.